Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00313521
What this trial is testing

Thiotepa and Radiation Therapy in Treating Young Patients With Newly Diagnosed Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group 30
Early research (Phase 1)Study completedNCT00357253
What this trial is testing

Capecitabine and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Nonmetastatic Brain Stem Glioma or High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02331498
What this trial is testing

Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Centre Antoine Lacassagne 51
Testing effectiveness (Phase 2)Study completedNCT00813943
What this trial is testing

Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Unmethylated Gene Promoter Status

Who this might be right for
Glioblastoma
EMD Serono 265
Early research (Phase 1)Study completedNCT00792012
What this trial is testing

A Dose Per Fraction Escalation Trial of Hypofractionated IMRT With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
University of Colorado, Denver 37
Early research (Phase 1)Study completedNCT03576612
What this trial is testing

GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas

Who this might be right for
Glioma, Malignant
Candel Therapeutics, Inc. 41
Not applicableUnknownNCT02520635
What this trial is testing

Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients

Who this might be right for
Glioblastoma
Beijing Tiantan Hospital 180
Testing effectiveness (Phase 2)Study completedNCT00004068
What this trial is testing

Irinotecan Followed by Radiation Therapy and Temozolomide in Treating Children With Newly Diagnosed Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 53
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Early research (Phase 1)Active Not RecruitingNCT04047706
What this trial is testing

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Northwestern University 18
Testing effectiveness (Phase 2)Looking for participantsNCT05664464
What this trial is testing

Glutamate Inhibitors in Glioblastoma

Who this might be right for
Glioblastoma
University of Zurich 120
Early research (Phase 1)Study completedNCT05698199
What this trial is testing

Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)

Who this might be right for
Glioblastoma
Immunomic Therapeutics, Inc. 10
Large-scale testing (Phase 3)UnknownNCT00003788
What this trial is testing

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Colorado Health Foundation 270
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Study completedNCT01280552
What this trial is testing

ICT-107 Immunotherapy in Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Precision Life Sciences Group 124
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Testing effectiveness (Phase 2)Study completedNCT02799238
What this trial is testing

Autologuos Lymphoid Effector Cells Specific Against Tumour (ALECSAT) as Add on to Standard of Care in Patients With Glioblastoma

Who this might be right for
Glioblastoma
CytoVac A/S 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019262
What this trial is testing

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
John Flickinger 2
Early research (Phase 1)Active Not RecruitingNCT05743595
What this trial is testing

Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Unmethylated Glioblastoma
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Looking for participantsNCT07346144
What this trial is testing

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Who this might be right for
Glioblastoma (GBM)High Grade GliomasRecurrent Glioblastoma+1 more
Trogenix ltd 68
Next Page